Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGLNASDAQ:GHNASDAQ:OPCHNASDAQ:RDNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGLagilon health$3.40-23.9%$4.27$1.50▼$7.73$1.40B0.384.89 million shs10.04 million shsGHGuardant Health$39.74-5.2%$43.70$18.01▼$52.92$4.92B1.492.22 million shs3.55 million shsOPCHOption Care Health$33.44+2.1%$33.33$21.39▼$35.53$5.48B0.761.83 million shs2.04 million shsRDNTRadNet$54.87+2.9%$50.58$45.00▼$93.65$4.12B1.46665,115 shs602,124 shsFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGLagilon health-24.30%-20.31%-20.02%+4.30%-31.83%GHGuardant Health-5.34%-15.86%-4.88%-13.78%+111.16%OPCHOption Care Health+2.14%+3.50%+1.73%+8.50%+10.29%RDNTRadNet+2.94%+4.75%+11.32%-14.75%+4.57%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGLagilon health2.5875 of 5 stars4.12.00.00.03.80.00.6GHGuardant Health4.7641 of 5 stars4.54.00.04.33.32.50.6OPCHOption Care Health3.0536 of 5 stars1.43.00.04.22.82.50.6RDNTRadNet3.9805 of 5 stars3.71.00.04.63.52.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGLagilon health 2.11Hold$4.8141.61% UpsideGHGuardant Health 3.05Buy$52.3231.65% UpsideOPCHOption Care Health 2.88Moderate Buy$35.506.16% UpsideRDNTRadNet 3.40Buy$69.7527.12% UpsideCurrent Analyst Ratings BreakdownLatest AGL, GH, OPCH, and RDNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$50.00 ➝ $60.005/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$52.00 ➝ $57.005/1/2025GHGuardant HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$60.00 ➝ $65.005/1/2025GHGuardant HealthTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$56.00 ➝ $60.005/1/2025GHGuardant HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$55.00 ➝ $60.005/1/2025GHGuardant HealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$53.00 ➝ $60.005/1/2025GHGuardant HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$65.00 ➝ $70.004/30/2025OPCHOption Care HealthBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$38.00 ➝ $38.004/30/2025OPCHOption Care HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$38.00 ➝ $40.004/28/2025AGLagilon healthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform(Data available from 5/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGLagilon health$6.06B0.23N/AN/A$1.63 per share2.08GHGuardant Health$774.00M6.36N/AN/A$1.34 per share29.66OPCHOption Care Health$5.19B1.06$1.95 per share17.19$8.03 per share4.16RDNTRadNet$1.83B2.25$2.92 per share18.81$11.79 per share4.65Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGLagilon health-$262.60M-$0.63N/AN/AN/A-6.88%-47.84%-14.97%N/AGHGuardant Health-$479.45M-$3.39N/AN/AN/A-59.05%-19,157.20%-25.96%N/AOPCHOption Care Health$267.09M$1.2428.1026.542.304.37%15.30%6.57%N/ARDNTRadNet$3.04M$0.03N/A103.53N/A-0.25%4.29%1.45%5/12/2025 (Estimated)Latest AGL, GH, OPCH, and RDNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025RDNTRadNet-$0.16N/AN/AN/A$442.98 millionN/A5/6/2025Q1 2025AGLagilon health-$0.01$0.03+$0.04$0.03$1.50 billion$1.53 billion4/30/2025Q1 2025GHGuardant Health-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billion2/27/2025Q4 2024RDNTRadNet$0.21$0.22+$0.01$0.07$459.42 million$477.10 million2/20/2025Q4 2024GHGuardant Health-$0.75-$0.90-$0.15-$0.90$192.50 million$201.81 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGLagilon health$1.8053.02%N/AN/A N/AGHGuardant HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGLagilon health0.061.291.29GHGuardant HealthN/A6.225.85OPCHOption Care Health0.771.731.32RDNTRadNet0.892.162.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGLagilon healthN/AGHGuardant Health92.60%OPCHOption Care Health98.05%RDNTRadNet77.90%Insider OwnershipCompanyInsider OwnershipAGLagilon health3.20%GHGuardant Health5.50%OPCHOption Care Health0.64%RDNTRadNet5.12%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGLagilon health650413.00 million398.83 millionNot OptionableGHGuardant Health1,790123.89 million116.76 millionNot OptionableOPCHOption Care Health5,600163.75 million169.09 millionOptionableRDNTRadNet8,97075.01 million70.24 millionOptionableAGL, GH, OPCH, and RDNT HeadlinesRecent News About These CompaniesRadNet (RDNT) Projected to Post Quarterly Earnings on MondayMay 7 at 11:07 AM | marketbeat.comRadNet, Inc. (NASDAQ:RDNT) Shares Acquired by Alyeska Investment Group L.P.May 6 at 5:31 AM | marketbeat.comSusquehanna Fundamental Investments LLC Buys Shares of 8,184 RadNet, Inc. (NASDAQ:RDNT)May 6 at 4:21 AM | marketbeat.comPrice T Rowe Associates Inc. MD Trims Stake in RadNet, Inc. (NASDAQ:RDNT)May 5 at 4:14 AM | marketbeat.comRadNet, Inc. (NASDAQ:RDNT) Position Boosted by First Trust Advisors LPMay 2, 2025 | marketbeat.comJim Cramer on RadNet, Inc. (RDNT): ‘If You’ve Got A Long-term Horizon, I Think It’s Going To Work For You’May 1, 2025 | insidermonkey.comHsbc Holdings PLC Sells 37,876 Shares of RadNet, Inc. (NASDAQ:RDNT)May 1, 2025 | marketbeat.comAnalysts Set RadNet, Inc. (NASDAQ:RDNT) Target Price at $69.75May 1, 2025 | americanbankingnews.comRadNet, Inc. (NASDAQ:RDNT) Shares Sold by Emerald Mutual Fund Advisers TrustApril 30, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Has $13.56 Million Stock Position in RadNet, Inc. (NASDAQ:RDNT)April 30, 2025 | marketbeat.comNewGen Asset Management Ltd Increases Stock Position in RadNet, Inc. (NASDAQ:RDNT)April 29, 2025 | marketbeat.comDimensional Fund Advisors LP Sells 220,728 Shares of RadNet, Inc. (NASDAQ:RDNT)April 29, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Purchases 404,241 Shares of RadNet, Inc. (NASDAQ:RDNT)April 28, 2025 | marketbeat.comRadNet, Inc. (NASDAQ:RDNT) Receives Consensus Rating of "Buy" from BrokeragesApril 28, 2025 | marketbeat.comPenn Capital Management Company LLC Cuts Stake in RadNet, Inc. (NASDAQ:RDNT)April 26, 2025 | marketbeat.comBarclays PLC Buys 8,592 Shares of RadNet, Inc. (NASDAQ:RDNT)April 26, 2025 | marketbeat.comHood River Capital Management LLC Increases Stake in RadNet, Inc. (NASDAQ:RDNT)April 25, 2025 | marketbeat.comHarvest Investment Services LLC Boosts Stake in RadNet, Inc. (NASDAQ:RDNT)April 24, 2025 | marketbeat.comRadNet, Inc. Announces Date of its First Quarter 2025 Financial Results Conference CallApril 24, 2025 | gurufocus.comRadNet, Inc. Announces Date of its First Quarter 2025 Financial Results Conference Call | RDNT ...April 24, 2025 | gurufocus.comRadNet, Inc. Announces Date of its First Quarter 2025 Financial Results Conference CallApril 24, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?5 Highest-Rated Dividend Stocks According to MarketBeatBy Thomas Hughes | April 10, 2025View 5 Highest-Rated Dividend Stocks According to MarketBeatJoby Aviation Shares Eye Breakout After Transition Flight WinBy Jeffrey Neal Johnson | April 30, 2025View Joby Aviation Shares Eye Breakout After Transition Flight WinTesla Stock Eyes Breakout With Earnings on DeckBy Sam Quirke | April 16, 2025View Tesla Stock Eyes Breakout With Earnings on DeckRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsBy Ryan Hasson | May 5, 2025View Rocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsAGL, GH, OPCH, and RDNT Company Descriptionsagilon health NYSE:AGL$3.40 -1.07 (-23.88%) Closing price 05/7/2025 03:59 PM EasternExtended Trading$3.38 -0.02 (-0.44%) As of 05/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Guardant Health NASDAQ:GH$39.74 -2.19 (-5.22%) Closing price 05/7/2025 04:00 PM EasternExtended Trading$39.90 +0.16 (+0.39%) As of 05/7/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Option Care Health NASDAQ:OPCH$33.44 +0.70 (+2.14%) Closing price 05/7/2025 04:00 PM EasternExtended Trading$33.43 -0.01 (-0.03%) As of 05/7/2025 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.RadNet NASDAQ:RDNT$54.87 +1.57 (+2.94%) Closing price 05/7/2025 03:59 PM EasternExtended Trading$54.24 -0.62 (-1.14%) As of 05/7/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Disney Stock Jumps on Earnings—Is the Magic Sustainable? AMD Relieves Market Despite Ongoing Share Price Outlook Caution Gold’s Record Run in 2025: Here Are 3 Ways to Ride the Surge What the New Quarter Says About Super Micro Computer's Future Archer Stock Eyes Q1 Earnings After UAE Updates Ford Motor Stock Rises After Earnings, But Momentum May Not Last Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx Boost Lemonade Delivers Sweet Results, Price Reversal to Accelerate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
